Page last updated: 2024-12-09

bicyclo(2.2.1)heptene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bicyclo(2.2.1)heptene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID638051
CHEBI ID52286
MeSH IDM0299226

Synonyms (17)

Synonym
unii-2q51fls550
2q51fls550 ,
ec 207-866-0
norfenchene
3,6-endomethylenecyclohexene
bicyclo(2.2.1)heptene
einecs 207-866-0
8,9,10-trinorborn-2-ene
bicyclo[2.2.1]hept-2-ene, 99%
CHEBI:52286
AKOS005259230
2-norbornen
(1r,4s)-bicyclo[2.2.1]hept-2-ene
mfcd00082304
norbornene, 99%
cis-norbornene
norbornene 100 microg/ml in acetonitrile

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The toxic effect of strained hydrocarbon 2,2'-bis (bicyclo[2."( Genotoxic effect of 2,2'-bis(bicyclo[2.2.1] heptane) on bacterial cells.
Bazhenov, S; Bermeshev, M; Gnuchikh, E; Kessenikh, A; Maksimov, A; Manukhov, I; Pevgov, V; Samoilov, V; Shorunov, S; Yaguzhinsky, L, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
bridged compoundA polycyclic compound in which two rings have two or more atoms in common.
carbobicyclic compoundA bicyclic compound in which all the ring atoms are carbon.
cyclic olefinThe inclusive term for any cyclic hydrocarbon having any number of double bonds.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's2 (16.67)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.76 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]